Vir Biotechnology Enrolls First Patient in Phase 3 ECLIPSE Registrational Program for Chronic Hepatitis Delta
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first patient in its Phase 3 ECLIPSE registrational program. The ECLIPSE registrational program is designed to evaluate the ...
Euronext N.V.: Euronext scales up its SaaS offering with the acquisition of Admincontrol
Euronext scales up its SaaS offering with the acquisition of Admincontrol Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris - 13 March 2025 - Euronext announces that it has entered into a ...